tirzepatide use in pregnancy Does Cause Birth Defects? Evidence and Safety Guidance Tirzepatide, Mounjaro, Period Changes and

[1] [2] Extensive clinical trial data from the SURPASS program (for diabetes) and SURMOUNT trials (for weight management) involving thousands of participants did not identify epistaxis as a significant adverse event associated with tirzepatide use

Tirzepatide is a GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus treatment Lightheadedness occurs through reduced fluid intake from gastrointestinal effects, blood pressure lowering from weight loss, or hypoglycaemia when combined with insulin or sulfonylureas Seek immediate medical attention for loss of consciousness, chest pain, severe confusion, or persistent vomiting preventing fluid intake Management includes maintaining adequate hydration (6-8 glasses daily), eating regular small meals, rising gradually from sitting or lying positions, and medication review with your GP Report frequent or concerning lightheadedness to your healthcare team within 24 hours for dose adjustment or investigation of alternative causes Table of Contents Why Mounjaro Can Cause Lightheadedness Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus

Patient selection: Healthcare providers should consider a patients personal and family medical history when prescribing these medications

The tirzepatide you inject is only as good as the pharmacy that compounds it

What Is Compounded Tirzepatide and How Does It Differ from Zepbound

Step 3: do not panic about early exposure This is the part where you need to take a breath